Skip to main content
LLY
NYSE Life Sciences

$2 Billion-Plus Biotech Acquisition: Eli Lilly in Advanced Talks for Kelonia Therapeutics

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$925.98
Mkt Cap
$875.875B
52W Low
$623.78
52W High
$1,133.95
52W Position info
48% above low
Off High info
18% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

LLY sits 48% above its 52-week low of $623.78.

Summary

Eli Lilly is reportedly in advanced talks to acquire biotech firm Kelonia Therapeutics for more than $2 billion, according to a Wall Street Journal report. This potential acquisition represents a significant strategic investment for the pharmaceutical giant, aiming to bolster its pipeline or technological capabilities. This news is distinct from recent updates regarding Eli Lilly's weight-loss drugs and Q4 earnings. While the $2 billion figure is material, it is a manageable amount for Eli Lilly's large market capitalization. Traders will be closely monitoring for a definitive announcement and further details on Kelonia's assets, which could provide insight into Eli Lilly's future growth vectors.

At the time of this announcement, LLY was trading at $925.98 on NYSE in the Life Sciences sector, with a market capitalization of approximately $875.9B. The 52-week trading range was $623.78 to $1,133.95. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 09, 2026, 10:23 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1,394.15
Real-time Price: $1,411.12 info
Change: +$16.97 (+1%) info
Market Cap: $1.328T info
LLY
Nov 06, 2026, 6:45 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,346.00
Real-time Price: $1,411.12 info
Change: +$65.12 (+5%) info
Market Cap: $1.328T info
LLY
Nov 04, 2026, 1:53 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,416.54
Real-time Price: $1,411.12 info
Change: -$5.42 (-0.38%) info
Market Cap: $1.328T info
LLY
Oct 29, 2026, 3:21 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1,368.10
Real-time Price: $1,411.12 info
Change: +$43.02 (+3%) info
Market Cap: $1.328T info
LLY
Oct 29, 2026, 12:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1,370.30
Real-time Price: $1,411.12 info
Change: +$40.82 (+3%) info
Market Cap: $1.328T info